Silexion Therapeutics Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Silexion Therapeutics Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.26M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.50M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($1.74M) | May 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($11.86M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($1.49M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.42M) | May 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($809.0K) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.88M) | Aug 29, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.29M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.28M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($1.65M) | May 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($8.04M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($1.39M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.25M) | May 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($731.0K) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.41M) | Aug 29, 2024 |